Abstract: The present invention provides three novel HSC genes designated SCM 3, SCM 26, and SCM 113, the coding regions thereof, the gene products, applications of the genes, DNA constructs, vectors and transformed cells each comprising the gene of a fragment thereof. Methods of using the SCM 3, SCM 26 and SCM 113 polynucleotide and polypeptide sequences are also disclosed.
Type:
Grant
Filed:
July 27, 1999
Date of Patent:
September 17, 2002
Assignee:
Novartis AG
Inventors:
Michael Paul Cooke, Claire Louise Holness, Oksana Ivanivna Sirenko